Efficacy of Group Intervention to Reduce Stress Symptoms
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00611338|
Recruitment Status : Unknown
Verified December 2009 by Stanford University.
Recruitment status was: Recruiting
First Posted : February 8, 2008
Last Update Posted : December 15, 2009
|Condition or disease||Intervention/treatment||Phase|
|Stress Disorders, Post-Traumatic HIV Infections||Behavioral: HIV Skills-based Prevention||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||290 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Efficacy of Group Intervention to Reduce Stress Symptoms|
|Study Start Date :||July 2006|
|Estimated Primary Completion Date :||August 2011|
|Estimated Study Completion Date :||August 2011|
- To determine if decreasing trauma-related stress symptoms improves HIV risk reduction behavior above a standard HIV risk reduction intervention alone post -intervention 3, 6, and 12 months after the group intervention sessions.
- To determine if decreasing trauma-related stress symptoms improves HIV risk reduction behavior above a standard HIV risk reduction intervention alone [ Time Frame: 15 months ]
- To determine whether key variables moderate the intervention's effects. For instance gender, age, ethnicity, or psychological distress (e.g. , depression, anxiety) may interact with the intervention to affect risky sexual or drug-related behavior.
- To determine whether key variables moderate the intervention's effects. [ Time Frame: 15 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00611338
|Contact: Susanne Lee, MPH||(650) email@example.com|
|United States, California|
|Stanford University School of Medicine||Recruiting|
|Stanford, California, United States, 94305|
|Contact: Susanne Lee, MPH 650-724-7025 firstname.lastname@example.org|
|Principal Investigator: Cheryl Gore-Felton Ph.D.|
|Sub-Investigator: Cheryl Koopman|
|Principal Investigator:||Cheryl Gore-Felton Ph.D.||Stanford University|